{"nctId":"NCT00980044","briefTitle":"Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal","startDateStruct":{"date":"2009-10"},"conditions":["Substance Withdrawal Syndrome"],"count":53,"armGroups":[{"label":"Tramadol 200 mg then placebo","type":"EXPERIMENTAL","interventionNames":["Drug: Tramadol"]},{"label":"Placebo for two weeks","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Tramadol 600 mg then placebo","type":"EXPERIMENTAL","interventionNames":["Drug: Tramadol"]}],"interventions":[{"name":"Tramadol","otherNames":["Brand name example: Ultram"]},{"name":"Placebo","otherNames":["Placebo is like a sugar pill"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Addicted to opioids\n\nExclusion Criteria:\n\n* Any major medical or psychiatric disorder that would be contraindicated for participation","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"55 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Subjective Opioid Withdrawal Total Adjective Score","description":"range of scores is 0-84; low scores indicate no opioid withdrawal, higher scores indicating more opioid withdrawal present. T","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"0.1"},{"groupId":"OG001","value":"7.7","spread":"0.1"},{"groupId":"OG002","value":"6.9","spread":"0.1"}]}]}]},{"type":"PRIMARY","title":"Total Number of Breakthrough Withdrawal Medication Doses Taken Week 1","description":"There were four medications (acetaminophen for aches/pains, zolpidem for trouble sleeping, bismuth subsalicylate for diarrhea, and alumina/magnesia/simethicone for nausea/upset stomach) available to all volunteers in all treatment arms to help relieve any withdrawal symptoms that were not relieved by the blinded tramadol/placebo doses.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"0.2"},{"groupId":"OG001","value":"2.5","spread":"0.2"},{"groupId":"OG002","value":"3.1","spread":"0.3"}]}]}]},{"type":"PRIMARY","title":"Subjective Opioid Withdrawal Adjective Total Score Week 2","description":"range of scores is 0-84; low scores indicate no opioid withdrawal, higher scores indicating more opioid withdrawal present","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":"0.2"},{"groupId":"OG001","value":"2.9","spread":"0.2"},{"groupId":"OG002","value":"2.7","spread":"0.1"}]}]}]},{"type":"PRIMARY","title":"Total Number of Breakthrough Withdrawal Medication Doses Taken Week 2","description":"There were four medications (acetaminophen for aches/pains, zolpidem for trouble sleeping, bismuth subsalicylate for diarrhea, and alumina/magnesia/simethicone for nausea/upset stomach) available to all volunteers in all treatment arms to help relieve any withdrawal symptoms that were not relieved by the blinded tramadol/placebo doses.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"0.2"},{"groupId":"OG001","value":"1.6","spread":"0.1"},{"groupId":"OG002","value":"3.2","spread":"0.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":17},"commonTop":["abdominal pain","unsteady urine flow without dysuria","sore throat/strep B","fleeting chest pain","left shoulder pain"]}}}